domingo, 28 de diciembre de 2014

Preliminary validation of a consumer-oriented colorectal cancer risk assessment tool compatible with the US Surgeon General's My Family Health Portrait : Genetics in Medicine : Nature Publishing Group

Preliminary validation of a consumer-oriented colorectal cancer risk assessment tool compatible with the US Surgeon General's My Family Health Portrait : Genetics in Medicine : Nature Publishing Group



Preliminary validation of a consumer-oriented colorectal cancer risk assessment tool compatible with the US Surgeon General’s My Family Health Portrait

Genetics in Medicine
 
(2014)
 
doi:10.1038/gim.2014.179
Received
 
Accepted
 
Published online 

Abstract

Purpose:

This study examines the analytic validity of a software tool designed to provide individuals with risk assessments for colorectal cancer based on personal health and family history information. The software is compatible with the US Surgeon General’s My Family Health Portrait (MFHP).

Methods:

An algorithm for risk assessment was created using accepted colorectal risk assessment guidelines and programmed into a software tool (MFHP). Risk assessments derived from 150 pedigrees using the MFHP tool were compared with “gold standard” risk assessments developed by three expert cancer genetic counselors.

Results:

Genetic counselor risk assessments showed substantial, but not perfect, agreement. MFHP risk assessments for colorectal cancer yielded a sensitivity for colorectal cancer risk of 81% (95% confidence interval: 54–96%) and specificity of 90% (95% confidence interval: 83–94%), as compared with genetic counselor pedigree review. The positive predictive value for risk for MFHP was 48% (95% confidence interval: 29–68%), whereas the negative predictive value was 98% (95% confidence interval: 93–99%). Agreement between MFHP and genetic counselor pedigree review was moderate (κ = 0.54).

Conclusion:

The analytic validity of the MFHP colorectal cancer risk assessment software is similar to those of other types of screening tools used in primary care. Future investigations should explore the clinical validity and utility of the software in diverse population groups.
Genet Med advance online publication 18 December 2014

Keywords:

 
colorectal cancer; family history; My Family Health Portrait; risk assessment tools

References

  1. Yoon PWScheuner MTKhoury MJResearch priorities for evaluating family history in the prevention of common chronic diseasesAm J Prev Med 2003;24:128135.
  2. Rich ECBurke WHeaton CJ, et al. Reconsidering the family history in primary careJ Gen Intern Med 2004;19:273280.
  3. Qureshi NCarroll JCWilson B, et al. The current state of cancer family history collection tools in primary care: a systematic reviewGenet Med 2009;11:495506.
  4. Reid GTWalter FMBrisbane JMEmery JDFamily history questionnaires designed for clinical use: a systematic reviewPublic Health Genomics 2009;12:7383.
  5. Orlando LABuchanan AHHahn SE, et al. Development and validation of a primary care-based family health history and decision support program (MeTree)NC Med J2013;74:287296.
  6. Qureshi NWilson BSantaguida P, et al. Family History and Improving Health. Evidence Report/Technology Assessment. Agency for Healthcare Research and Quality. 2009:1135.http://www.ahrq.gov/research/findings/evidence-based-reports/famhimp-evidence-report.pdf.
  7. Special report: exome sequencing for clinical diagnosis of patients with suspected genetic disordershttp://www.bcbs.com/blueresources/tec/vols/28/28_03.pdf. Accessed 19 December 2013.
  8. Yoon PWScheuner MTJorgensen CKhoury MJDeveloping Family Healthware, a family history screening tool to prevent common chronic diseasesPrev Chronic Dis 2009;6:A33.
  9. Facio FMFeero WGLinn AOden NManickam KBiesecker LGValidation of My Family Health Portrait for six common heritable conditionsGenet Med 2010;12:370375.
  10. Feero WGBigley MBBrinner KMFamily Health History Multi-Stakeholder Workgroup of the American Health Information CommunityNew standards and enhanced utility for family health history information in the electronic health record: an update from the American Health Information Community’s Family Health History Multi-Stakeholder WorkgroupJ Am Med Inform Assoc 2008;15:723728.
  11. Owens KMMarvin MLGelehrter TDRuffin MT 4thUhlmann WRClinical use of the Surgeon General’s “My Family Health Portrait” (MFHP) tool: opinions of future health care providersJ Genet Couns 2011;20:510525.
  12. Kanetzke EELynch JProws CASiegel RMMyers MFPerceived utility of parent-generated family health history as a health promotion tool in pediatric practiceClin Pediatr (Phila) 2011;50:720728.
  13. The US Surgeon General’s My Family Health Portrait.https://familyhistory.hhs.gov/FHH/html/index.html. Accessed 2 July 2012.
  14. Valdez RYoon PWQureshi NGreen RFKhoury MJFamily history in public health practice: a genomic tool for disease prevention and health promotionAnnu Rev Publ Health2010;31:6987 1 p following 87.
  15. Biesecker LGMullikin JCFacio FM, et al.; NISC Comparative Sequencing ProgramThe ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine.Genome Res 2009;19:16651674.
  16. Qureshi NBethea JModell B, et al. Collecting genetic information in primary care: evaluating a new family history toolFam Pract 2005;22:663669.
  17. Landis JRKoch GGThe measurement of observer agreement for categorical data.Biometrics 1977;33:159174.
  18. Roberts NJVogelstein JTParmigiani GKinzler KWVogelstein BVelculescu VEThe predictive capacity of personal genome sequencingSci Transl Med 2012;4:133ra158.
  19. Taylor DPStoddard GJBurt RW, et al. How well does family history predict who will get colorectal cancer? Implications for cancer screening and counselingGenet Med2011;13:385391.
  20. Madlensky LDaftary DBurnett T, et al. Accuracy of colorectal polyp self-reports: findings from the colon cancer family registryCancer Epidemiol Biomarkers Prev2007;16:18981901.

Author information

Affiliations

  1. Maine-Dartmouth Family Medicine Residency, Fairfield, Maine, USA

    • W. Gregory Feero
  2. Inova Translational Medicine Institute, Falls Church, Virginia, USA

    • Flavia M. Facio
  3. Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

    • Emily A. Glogowski
  4. Division of Human Genetics, The Ohio State University, Columbus, Ohio, USA

    • Heather L. Hampel
  5. Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA

    • Jill E. Stopfer
  6. Department of Genetics, Vanderbilt University, Nashville, Tennessee, USA

    • Haley Eidem
  7. White Matter Disease Program, Children’s National Health System, Washington, DC, USA

    • Amy M. Pizzino
  8. Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, USA

    • David K. Barton
  9. Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA

    • Leslie G. Biesecker

Corresponding author

Correspondence to: 

No hay comentarios:

Publicar un comentario